United States
US 12,697,335 B2
Method for treating immune toxicities induced by immune checkpoint inhibitors
US 12,697,335 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM); SORBONNE UNIVERSITÉ; ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM); SORBONNE UNIVERSITÉ; ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS
- Inventors
- Yves ALLENBACH; Joe-Elie SALEM; Céline ANQUETIL
- Publication date
- 2026-08-04
- Filing date
- 2023-01-30
- Document type
- B2 Granted patent
- Also written as
- US 12,697,335 B2 · US12697335 · 12697335
Abstract
The invention relates to the use of a JAK inhibitor for treating or preventing adverse events in patient treated with an immune checkpoint inhibitor, or for treating cancer in combination with an immune checkpoint inhibitor.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free